Keeping Current CME

Mar 2, 2026

Do you know how many different types of anti-HER2 therapies are in clinical trials for gastroesophageal adenocarcinoma (GEA)?

Credit available for this activity expires: 02/27/2027
Earn Credit / Learning Objectives & Disclosures:

Feb 23, 2026

Transforming CLL care: measurable residual disease (MRD) guided stopping, smart triplet selection, and next‑gen Bruton tyrosine kinase (BTKs)—practical insights.
 
Credit available for this activity expires: 02/19/27

Earn Credit / Learning Objectives & Disclosures:

Feb 20, 2026

Are you up to date on the management of extensive-stage small cell lung cancer (ES-SCLC)?

Credit available for this activity expires: 2/20/27
Earn Credit / Learning Objectives & Disclosures:

Feb 20, 2026

Clear communication builds trust in biosimilars. 

Credit available for this activity expires: 2/19/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003245?ecd=bdc_podcast_libsyn_mscpedu

Feb 12, 2026

Early evidence for CAR T-cell therapy in lupus is compelling. Are you up-to-date?

Credit available for this activity expires: 2/9/26
Earn Credit / Learning Objectives & Disclosures: